Sarpogrelate

Sarpogrelate is a selective 5-HT2A (serotonin) receptor antagonist with potent antiplatelet and vasodilatory activity. Mediocon Inc supplies pharmaceutical-grade Sarpogrelate conforming to IP / BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.

Sarpogrelate inhibits serotonin-mediated platelet aggregation and vasoconstriction. It is used clinically in Japan and other Asian markets for the treatment of chronic arterial occlusion and peripheral vascular disease.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Peripheral artery disease treatment
• Antiplatelet therapy formulations
• Cerebrovascular ischaemia prevention
• Thrombosis R&D

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings

Parameter	Specification
Assay	NLT 98.0%
Loss on Drying	NMT 0.5%
Heavy Metals	NMT 20 ppm
Residue on Ignition	NMT 0.1%
Microbial Limits	Complies with pharmacopoeia
Identification	IR, HPLC Compliant
Mfg Date	MAR 2025
Exp Date	FEB 2030
Packing	25 kg HDPE drums / as per requirement